These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 9865255

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. FK506 for primary and rescue therapy following liver transplantation.
    Platz KP, Mueller AR, Zytowski M, Lobeck H, Neuhaus P.
    Transplant Proc; 1998 Jun; 30(4):1409-10. PubMed ID: 9636570
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
    Bilbao I, Pou L, Allende E, Lázaro JL, Charco R, Hidalgo E, Margarit C.
    Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. One-year follow-up of a Brazilian randomized multicenter study comparing tacrolimus versus cyclosporine in kidney transplantation.
    Campos HH, Abbud Filho M, Brazilian Tacrolimus Study Group.
    Transplant Proc; 2002 Aug; 34(5):1656-8. PubMed ID: 12176523
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantation.
    Klupp J, Bechstein WO, Pratschke J, Tullius SG, Gebhard A, Lobeck H, Langrehr JM, Neuhaus R, Neuhaus P.
    Transplant Proc; 1998 Jun; 30(4):1443-4. PubMed ID: 9636585
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Impact of immunosuppression in liver transplantation across a positive crossmatch.
    Lang M, Neumann U, Knoop M, Bechstein WO, Neuhaus P.
    Transplant Proc; 1998 Jun; 30(4):1466-7. PubMed ID: 9636595
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):635-7. PubMed ID: 7679826
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients.
    Marcus N, Khaghani A, Burke M, Yacoub M, Banner N.
    Transplant Proc; 1998 Jun; 30(4):1134-5. PubMed ID: 9636460
    [No Abstract] [Full Text] [Related]

  • 20. Prospective evaluation of a quadruple therapy based on tacrolimus after liver transplantation.
    Lladó L, Figueras J, Ramos E, Lama C, Busquets J, Ibáñez L, Rafecas A, Fabregat J, Torras J, Jaurrieta E.
    Transplant Proc; 2002 Feb; 34(1):108. PubMed ID: 11959210
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.